Responsive Banner

Immunosuppressive activity of goat kefir in a rat model with bleomycin-induced pulmonary fibrosis

Griana, Tias Pramesti ORCID: https://orcid.org/0000-0002-2974-0884, Raras, Tri Yudani Mardining, Mintaroem, Karyono, Chozin, Iin Noor and Wilujeng, Catur Saptaning (2020) Immunosuppressive activity of goat kefir in a rat model with bleomycin-induced pulmonary fibrosis. Pharmacognosy Journal, 12 (6). pp. 1594-1599. ISSN 0975-3575

[img]
Preview
Text
7469.pdf - Published Version
Available under License Creative Commons Attribution.

Download (2MB) | Preview

Abstract

Objective: This study aimed to investigate the immunomodulatory capacity of goat kefir on pulmonary fibrosis rat model. Material and Methods: Twenty-five male rats were randomly divided into five groups: one group only received induction with bleomycin (0.3 mg/rat) to induce pulmonary fibrosis; three groups were treated with different doses (2.5, 3.5, and 4.5 mL/200 g BW) of goat kefir, following the induction with bleomycin, for 30 days; and one group served as negative control, did not receive bleomycin induction as well as kefir. On day 30, all the animals were sacrificed. Plasma levels of TGF-β, IL-4, and IFN-y were measured using the ELISA method, and the expression of α-SMA in myofibroblast cells was examined with the help of immunohistochemistry assay. Results: Induction with bleomycin significantly elevated the expressions of TGF-β, IL-4, and IFN-y in comparison to the control group. Following the administration of kefir (3.5 and 4.5 mL/200 g BW), the concentration of TGF-β was significantly decreased (p<0.05); whereas, the concentration of IFN-y increased slightly (p<0.05) only in the group that received the 4.5 mL/200 g BW dose of kefir. In contrast, IL-4 exhibited increasing levels with higher doses of kefir (p<0.05). The expression of α-SMA in myofibroblasts showed a tendency to decline following the administration of kefir, although this decline was not statistically significant. Conclusions: Goat kefir caused a reduction in the TGF-β levels in fibrosis conditions; however, the kefir elicited an immunosuppressive effect during the progression of the pulmonary fibrosis.

Item Type: Journal Article
Keywords: Bleomycin; Cytokine; Immunomodulator; Kefir; Pulmonary fibrosis
Subjects: 11 MEDICAL AND HEALTH SCIENCES > 1107 Immunology > 110705 Humoural Immunology and Immunochemistry
Depositing User: dr. Tias Pramesti Griana
Date Deposited: 29 Nov 2020 08:02

Downloads

Downloads per month over past year

Loading...

Origin of downloads

Loading...

Actions (login required)

View Item View Item
Sorry the service is unavailable at the moment. Please try again later.